Michael K Keng[Author] - Search Results

Year	Number of Results
2007	1
2012	1
2013	3
2015	1
2019	3
2020	3
2021	3
2022	2
2024	1

1

Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.

Riley DO, Schlefman JM, Vitzthum Von Eckstaedt V HC, Morris AL, Keng MK, El Chaer F. Riley DO, et al. Among authors: keng mk. Curr Hematol Malig Rep. 2021 Jun;16(3):314-324. doi: 10.1007/s11899-021-00638-0. Epub 2021 May 12. Curr Hematol Malig Rep. 2021. PMID: 33978914 Review.

2

Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.

Ung J, Tan SF, Fox TE, Shaw JJP, Vass LR, Costa-Pinheiro P, Garrett-Bakelman FE, Keng MK, Sharma A, Claxton DF, Levine RL, Tallman MS, Cabot MC, Kester M, Feith DJ, Loughran TP Jr. Ung J, et al. Among authors: keng mk. Blood Rev. 2022 Sep;55:100950. doi: 10.1016/j.blre.2022.100950. Epub 2022 Apr 9. Blood Rev. 2022. PMID: 35487785 Free PMC article. Review.

3

Febrile neutropenia in hematologic malignancies.

Keng MK, Sekeres MA. Keng MK, et al. Curr Hematol Malig Rep. 2013 Dec;8(4):370-8. doi: 10.1007/s11899-013-0171-4. Curr Hematol Malig Rep. 2013. PMID: 23990311 Review.

4

A drug's life: the pathway to drug approval.

Keng MK, Wenzell CM, Sekeres MA. Keng MK, et al. Clin Adv Hematol Oncol. 2013 Oct;11(10):646-55. Clin Adv Hematol Oncol. 2013. PMID: 24518374 Review.

5

Reducing Repeat Blood Cultures in Febrile Neutropenia: A Single-Center Experience.

Robinson ED, Keng MK, Thomas TD, Cox HL, Park SC, Mathers AJ. Robinson ED, et al. Among authors: keng mk. Open Forum Infect Dis. 2022 Oct 14;9(11):ofac521. doi: 10.1093/ofid/ofac521. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36408469 Free PMC article.

6

Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.

Reed DR, Sen JM, Pierce EJ, Elsarrag RZ, K Keng M. Reed DR, et al. Among authors: k keng m. J Oncol Pharm Pract. 2020 Jul;26(5):1200-1212. doi: 10.1177/1078155220918006. Epub 2020 Apr 26. J Oncol Pharm Pract. 2020. PMID: 32338136 Review.

7

Granulocytic Sarcoma: A Rare Cause of Wrist Pain.

Schaeffer CV, Moran TE, Keng MK, Bateman HR, DeGeorge BR Jr. Schaeffer CV, et al. Among authors: keng mk. Ann Plast Surg. 2020 Jul;85(1):29-32. doi: 10.1097/SAP.0000000000002315. Ann Plast Surg. 2020. PMID: 32149843

8

Adapting isotonic dose-finding to a dynamic set of drug combinations with application to a phase I leukemia trial.

Wages NA, Reed DR, Keng MK, Conaway MR, Petroni GR. Wages NA, et al. Among authors: keng mk. Clin Trials. 2021 Jun;18(3):314-323. doi: 10.1177/1740774520983484. Epub 2021 Jan 10. Clin Trials. 2021. PMID: 33426919 Free PMC article.

9

Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia.

Isaac KM, Reed DR, Desai RP, Williams E, Balkrishnan R, Keng MK, Ballen KK. Isaac KM, et al. Among authors: keng mk. Cancer Rep (Hoboken). 2021 Aug;4(4):e1354. doi: 10.1002/cnr2.1354. Epub 2021 Mar 9. Cancer Rep (Hoboken). 2021. PMID: 33751859 Free PMC article.

10

Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment.

Reed DR, Elsarrag RZ, Morris AL, Keng MK. Reed DR, et al. Among authors: keng mk. Cancer Manag Res. 2019 Aug 30;11:8073-8080. doi: 10.2147/CMAR.S162784. eCollection 2019. Cancer Manag Res. 2019. PMID: 31564968 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year